PEPperPRINT Webinar – Guilty by association: Identifying real autoantibody responses from a proteome-wide screen

PEPperPRINT Webinar – Guilty by association: Identifying real autoantibody responses  from a proteome-wide screen

PEPperPRINT Webinar

Guilty by association: Identifying real autoantibody responses
from a proteome-wide screen

📅 Date: Tuesday, 29 September 2026
đź•“ Time: 16:00 CEST / 10:00 EDT

How do you go from broad antigen discovery to focused peptide hit validation?

Join Luke Marshall as he takes us behind the scenes of Biotome‘s biomarker discovery workflow for Idiopathic Pulmonary Fibrosis. From proteome-wide autoantibody response screening using the PhIP-Seq platform, to epitope-level target validation with peptide microarrays, learn how potential candidates are selected and targets are validated, and what it takes to deliver a peptide panel to a real-world diagnostic.

 

What you’ll learn 

  • Best of both worlds: how to combine the library size of PhIP-Seq with the epitope-level precision, sensitivity, and reproducibility of PEPperCHIP® Peptide Microarrays
  • Strengths and limitations of both platforms, which information transfers well, and how combined data can be used to make key candidate selection decisions
  • Major considerations for protein target selection, multi-antibody isotope response validation, and target peptide stabilization for downstream applications

 

Who should attend 

  • Scientists using (or considering) PhIP-Seq, peptide microarrays or other high-throughput antibody profiling technologies
  • Scientists working in antibody-based serology, diagnostics, or assay development
  • Researchers working on idiopathic pulmonary fibrosis and other immune-mediated diseases
  • Teams looking to translate discovery data into clinically relevant applications

 

 Sign up for free

 

—-

 

NEWSLETTER

https://us06web.zoom.us/webinar/register/7017888700128/WN_IFXXOfv4RV21BDsLHiPYEQ

register now

Our latest News

discover more
AlphaFold Database adds viral protein complexes to support pandemic preparedness

AlphaFold Database adds viral protein complexes to support pandemic preparedness

by Sera Guli The latest release includes protein structure predictions for thousands of viruses, which could improve the response to future outbreaks AI-predicted protein complex structures for over 2,800 viruses are now openly available in the AlphaFold Database. To better understand and protect against emerging pathogens, the dataset prioritises proteomes from viral families known to […]

European Commission grants €57 million to critical open data resources

European Commission grants €57 million to critical open data resources

Horizon Europe funding will support GENCODE, UniProt, and Europe PMC The European Commission has announced €57 million in funding to support GENCODE, UniProt, and Europe PMC. These life sciences data resources are delivered and managed by EMBL’s European Bioinformatics Institute (EMBL-EBI) alongside international partners. The financial support will be given in the shape of three […]

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies. The […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp